Tu ST - Search Results

1

Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin.

Lo HC, Hsu TH, Tu ST, Lin KC. Lo HC, et al. Among authors: tu st. Am J Chin Med. 2006;34(5):819-32. doi: 10.1142/S0192415X06004314. Am J Chin Med. 2006. PMID: 17080547

2

The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin.

Lo HC, Tu ST, Lin KC, Lin SC. Lo HC, et al. Among authors: tu st. Life Sci. 2004 Apr 23;74(23):2897-908. doi: 10.1016/j.lfs.2003.11.003. Life Sci. 2004. PMID: 15050427

3

Characteristics predicting dyslipidemia in drug-naïve type 2 diabetes patients.

Lin SD, Tu ST, Hsu SR, Lin KC, Sheu WH. Lin SD, et al. Among authors: tu st. J Chin Med Assoc. 2006 Sep;69(9):404-8. doi: 10.1016/S1726-4901(09)70282-5. J Chin Med Assoc. 2006. PMID: 17051750 Free article.

4

Metabolic control with insulin pump therapy: preliminary experience.

Hsu SR, Lin SD, Tu ST, Liao PY, Su SL, Lin SL, Tseng YY, Huang PW. Hsu SR, et al. Among authors: tu st. J Chin Med Assoc. 2008 Jul;71(7):353-6. doi: 10.1016/S1726-4901(08)70138-2. J Chin Med Assoc. 2008. PMID: 18653398 Free article.

5

Use of expert consensus to improve the diagnosis and management of type 1 diabetes mellitus.

Lin CH, Tung YC, Chang TJ, Huang CN, Hwu CM; for Taiwan Type 1 DM Consortium. Lin CH, et al. J Chin Med Assoc. 2022 Jul 1;85(7):741-746. doi: 10.1097/JCMA.0000000000000751. Epub 2022 Jun 30. J Chin Med Assoc. 2022. PMID: 35648167

6

Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis.

Tu ST, Chang SJ, Chen JF, Tien KJ, Hsiao JY, Chen HC, Hsieh MC. Tu ST, et al. Arch Intern Med. 2010 Jan 25;170(2):155-61. doi: 10.1001/archinternmed.2009.471. Arch Intern Med. 2010. PMID: 20101010

7

Carotid intima-media thickness and stiffness are independent risk factors for atherosclerotic diseases.

Tu ST, Wang IW, Lin HF, Liao YC, Lin RT, Liu CS, Juo SH. Tu ST, et al. J Investig Med. 2010 Aug;58(6):786-90. doi: 10.231/JIM.0b013e3181e8019d. J Investig Med. 2010. PMID: 20571440

8

Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.

Tien KJ, Tu ST, Chou CW, Yang CY, Hsiao JY, Shin SJ, Chen HC, Hsieh MC. Tien KJ, et al. Among authors: tu st. Am J Nephrol. 2011;33(3):231-8. doi: 10.1159/000324561. Epub 2011 Feb 23. Am J Nephrol. 2011. PMID: 21346330

9

The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.

Lin SD, Wang JS, Hsu SR, Sheu WH, Tu ST, Lee IT, Su SL, Lin SY, Wang SY, Hsieh MC. Lin SD, et al. Among authors: tu st. J Diabetes Complications. 2011 Sep-Oct;25(5):332-8. doi: 10.1016/j.jdiacomp.2011.06.004. Epub 2011 Aug 2. J Diabetes Complications. 2011. PMID: 21813293 Clinical Trial.

10

Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes.

Lin SD, Tsai ST, Tu ST, Su CC, Chen JF, Lu CH, Wang CH, Yu NC, Hsu SR, Hsieh MC. Lin SD, et al. Among authors: tu st. Prim Care Diabetes. 2015 Apr;9(2):135-41. doi: 10.1016/j.pcd.2014.05.005. Epub 2014 Sep 27. Prim Care Diabetes. 2015. PMID: 25266893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters